dr. lara on epacadostat plus pembrolizumab in rcc
Published 7 years ago • 171 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:10
dr. lara discusses epacadostat in renal cell carcinoma
-
1:50
dr. hamid on epacadostat plus pembrolizumab in advanced melanoma
-
1:05
dr. tara gangadhar on epacadostat/ pembrolizumab combination
-
1:23
dr. lara on the role of sunitinib for renal cell carcinoma
-
2:20
dr. lara on the fda approval of adjuvant sunitinib in rcc
-
1:56
dr. cost on pembrolizumab plus axitinib in patients with rcc
-
1:37
dr. lara on the potential role of ido inhibitors in the treatment of rcc
-
2:17
dr. chowdhury on pembrolizumab plus pazopanib in rcc
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
1:19
dr. rini on the efficacy of axitinib and pembrolizumab in rcc
-
1:40
dr. powles on fda approval of pembrolizumab plus axitinib in advanced rcc
-
2:25
dr. tykodi on the keynote-427 trial with pembrolizumab in rcc
-
1:03
dr. rini on managing the toxicity of pembrolizumab plus axitinib in mrcc
-
0:58
dr. chowdhury on separate roles of pazopanib and pembrolizumab in rcc
-
1:14
dr. jonasch on single-agent pembrolizumab in non-clear cell rcc
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
1:58
dr. mcdermott on single-agent pembrolizumab in advanced rcc
-
2:35
key data from asco gu 2019 on mrcc: pembrolizumab and axitinib as first-line therapy
-
1:04
dr. rini discusses pembrolizumab plus axitinib in mrcc